1. Home
  2. PBLS vs LION Comparison

PBLS vs LION Comparison

Compare PBLS & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.63

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

N/A

Current Price

$13.26

Market Cap

4.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
PBLS
LION
Founded
N/A
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.1B
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
PBLS
LION
Price
$31.63
$13.26
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$11.89
AVG Volume (30 Days)
451.4K
2.3M
Earning Date
N/A
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,631,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.56
$5.65
52 Week High
$33.65
$16.70

Technical Indicators

Market Signals
Indicator
PBLS
LION
Relative Strength Index (RSI) 57.89 42.10
Support Level $26.83 $13.14
Resistance Level $33.65 $14.78
Average True Range (ATR) 2.51 0.54
MACD 0.16 -0.08
Stochastic Oscillator 69.57 15.31

Price Performance

Historical Comparison
PBLS
LION

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: